Skip to main content

Table 1 Demographic and clinical characteristics of patients

From: High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival

 

Age range

Indian American

Ethnicitya

pTNM

Stage

Histological differentiation

Survival (Months)

Adjuvant Treatment

CD3

CD4

CD8

FoxP3

1

30/79

No

TisN0M0

0

In Situ

60

No

5

7

8

0

2

 

ND

TisN0M0

0

In Situ

48

No

36

24

16

8

3

 

No

TisN0M0

0

In Situ

60

No

34

23

22

4

4

Yes

TisN0M0

0

In Situ

60

No

20

16

1

5

17

 

No

TisN0M0

0

In Situ

60

No

46

39

18

2

6

 

ND

T1bN0M0

I

Moderate

18

No

38

27

12

2

7

 

No

T1bN0M0

I

Well

60

No

2

2

2

0

8

 

No

T1aN0M0

I

Well

60

No

14

21

46

2

9

 

ND

T1bN0M0

I

Well

3

No

22

17

20

1

10

 

ND

T1aN0M0

I

Well

60

No

32

24

19

2

11

 

No

T1bN0M0

I

Well

60

No

36

16

32

0

12

 

No

T1bN0M0

I

Poorly

60

No

28

22

19

0

13

 

No

T1aN0M0

I

Well

60

No

14

18

10

0

14

 

No

T1aN0M0

I

Moderate

60

No

20

18

23

0

15

 

No

T1bN0M0

I

Moderate

60

No

15

14

22

0

16

 

No

T1bN0M0

I

Well

29

CT + RT

16

12

10

8

18

 

Yes

T1bN0M0

I

Moderate

60

No

28

14

27

0

19

 

No

T1bN0M0

I

Well

60

CT + RT

42

26

26

17

20

 

Yes

T1bN0M0

I

Moderate

0

No

15

8

0

9

21

38/85

No

T2N0M0

II

Poorly

0

No

12

1

14

3

22

 

No

T2N0M0

II

Moderate

60

ND

26

15

24

0

23

 

No

T2N0M0

II

Well

60

ND

21

15

38

5

24

 

N.D

T2N0M0

II

Moderate

13

ND

13

11

2

2

25

 

ND

T2N0M0

II

Moderate

22

ND

18

14

11

6

26

 

No

T2N0M0

II

Moderate

6

ND

24

31

2

1

27

 

No

T2N0M0

II

Moderate

60

CT + RT

22

23

17

3

28

 

No

T2N0M0

II

Moderate

0

No

19

18

14

7

29

 

No

T2N0M0

II

Poorly

7

ND

13

13

3

0

30

 

Yes

T3N0M0

IIIA

Poorly

3

No

18

7

8

0

31

 

No

T3N0M0

IIIA

Moderate

60

No

34

4

25

0

32

 

No

T3N0M0

IIIA

Well

19

ND

23

17

34

1

33

 

No

T3N0M0

IIIA

Poorly

4

No

80

70

38

5

34

 

No

T3N0M0

IIIA

Moderate

8

No

21

22

8

1

35

 

No

T3N0M0

IIIA

Well

60

ND

24

25

7

0

36

 

No

T3N0M0

IIIA

Moderate

11

No

27

11

22

1

37

 

No

T3N0M0

IIIA

Moderate

3

No

45

20

6

1

38

 

No

T3N0M0

IIIA

Moderate

2

No

16

20

5

9

39

 

ND

T3N0M0

IIIA

Moderate

60

ND

36

10

31

20

40

 

ND

T3N0M0

IIIA

Poorly

6

ND

ND

32

ND

ND

41

 

No

T3N0M0

IIIA

Poorly

4

No

18

23

21

5

42

 

ND

T3N0M0

IIIA

Moderate

4

ND

22

10

16

13

43

 

No

T3N0M0

IIIA

Poorly

60

CT

12

13

26

7

44

 

No

T3N0M0

IIIA

Moderate

0

No

10

12

8

2

45

 

No

T3N0M0

IIIA

Well

0

No

16

14

3

8

46

 

No

T3N0M0

IIIA

Poorly

5

ND

39

30

32

4

47

 

No

T3N0M0

IIIA

Moderate

3

No

15

5

4

3

48

 

ND

T3N0M0

IIIA

Moderate

4

ND

10

11

18

0

49

 

ND

T3N0M0

IIIA

Moderate

6

ND

25

25

19

10

50

 

Yes

T3N0M0

IIIA

Poorly

11

ND

26

15

7

0

51

 

No

T3N0M0

IIIA

Moderate

9

ND

22

19

9

3

52

 

No

T3N0M0

IIIA

Moderate

1

No

5

6

8

0

53

 

No

T3N0M0

IIIA

Poorly

2

No

11

9

12

6

54

 

No

T3N0M0

IIIA

Moderate

5

ND

37

17

30

0

55

 

ND

T3N0M0

IIIA

Moderate

4

ND

12

12

21

7

56

 

No

T3N0M0

IIIA

Poorly

1

No

37

42

0

1

57

 

No

T3N0M0

IIIA

Moderate

2

No

14

10

0

6

58

 

No

T3N0M0

IIIA

Moderate

4

No

10

7

0

1

59

 

No

T2N1M0

IIIB

Moderate

60

ND

37

15

54

11

60

 

No

T2N1M0

IIIB

Poorly

60

CT + RT

17

6

25

1

61

 

ND

T3N1M0

IIIB

Poorly

5

ND

28

20

17

4

62

 

ND

T3N1M0

IIIB

Moderate

16

ND

15

14

19

1

63

 

No

T3N1M0

IIIB

Moderate

5

No

32

19

27

15

64

 

No

T2N1M0

IIIB

Well

60

CT + RT

40

31

36

2

65

 

No

T2N1M0

IIIB

Moderate

7

ND

21

19

10

1

66

 

ND

T3N1M0

IIIB

Poorly

5

No

20

17

26

26

67

 

Yes

T2N1M0

IIIB

Poorly

60

ND

30

18

30

0

68

 

No

T2N1M0

IIIB

Moderate

10

CT + RT

19

14

17

7

69

 

ND

T3N1M0

IIIB

Poorly

11

CT + RT

28

31

32

10

70

 

No

T2N1M0

IIIB

Moderate

60

CT + RT

23

21

33

5

71

 

No

T2N1M0

IIIB

Moderate

51

ND

23

12

13

1

72

 

ND

T3N1M0

IIIB

Poorly

2

No

33

8

16

0

73

 

No

T3N1M0

IIIB

Moderate

12

ND

11

14

17

10

74

 

No

T2N1M0

IIIB

Poorly

60

CT + RT

23

13

10

2

75

 

No

T4N1M0

IVA

Poorly

3

No

45

40

12

3

76

 

No

T4N0M0

IVA

Moderate

9

ND

20

26

8

ND

77

 

No

T3N2M0

IVB

Moderate

34

CT + RT

13

16

19

0

78

 

No

T3N2M0

IVB

Moderate

14

ND

27

18

0

1

79

 

No

T3N2M0

IVB

Poorly

9

ND

51

44

34

5

  1. aMapuche ethnical origin was assessed by correlation with patient parents last, family, or middle name
  2. ND No Data, CT Chemotherapy, RT Radiotherapy. White = early stage of disease. Light grey = Late stage of disease